Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for Chronic Inhibition of HDAC Activity in the CNS In Vivo

Overview of attention for article published in PLOS ONE, September 2012

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 54 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,151 followers.

Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for ....... http://t.co/8McD9J01 Huntington's disease

Reply Repost Favourite